comparemela.com

Latest Breaking News On - Neurosciences - Page 6 : comparemela.com

Global Neuroscience Antibodies & Assays Market Report 2023:

Dublin, March 31, 2023 (GLOBE NEWSWIRE) The "Neuroscience Antibodies & Assays Global Market Report 2023" report has been added to .

Indonesia
Australia
Russia
France
United-kingdom
United-states
China
South-korea
Switzerland
Brazil
Belgium
Japan

Lead Therapeutic Candidate, PMN310, Demonstrates Enhanced Selectivity for Toxic Oligomers Compared to Other Amyloid-Beta-Directed Antibodies in Poster Presentation at AD/PD 2023

TORONTO, Ontario and CAMBRIDGE, Massachusetts, March 29, 2023 ProMIS Neurosciences Inc. , a biotechnology company focused on the generation and development of antibody therapeutics. | March 29, 2023

Massachusetts
United-states
Cambridge
Cambridgeshire
United-kingdom
Toronto
Ontario
Canada
Johanne-kaplan
Suzanne-messere
Promis-neurosciences-inc
Toronto-stock-exchange

People with epilepsy at increased risk of early death: Study

The increased risk also varies depending on where people with epilepsy live, the number of medications they take and what other diseases they may have

South-korea
India
Seo-young-lee
Ravindra-srivastava
Kangwon-national-university-in-chuncheon
Purple-day
Kangwon-national-university
Primus-super-speciality-hospital
Health-risks
Epilepsy
Death-rate
Risk-of-death

Cognetivity Neurosciences Ltd.: Cognetivity Neurosciences Enters Commercial Agreement with UK-Based Brain Health Supplements Provider

Agreement sees Cognetivity expand commercial offering into sports and fitness market, with cutting-edge assessment and monitoring technology made available to customers of brain health supplement subscription

United-states
Canada
United-kingdom
Vancouver
British-columbia
British
Canadian
Dennis-riedl
Humphrey-bodington
Sina-habibi
Cognetivity-neurosciences-ltd
Company-or-cognetivity

Promis Neurosciences to Present at the Oppenheimer 33rd Annual Healthcare Conference

TORONTO, Ontario and CAMBRIDGE, Massachusetts, March 08, 2023 ProMIS Neurosciences Inc. , a biotechnology company focused on the generation and development of antibody therapeutics. | March 8, 2023

Cambridge
Cambridgeshire
United-kingdom
Toronto
Ontario
Canada
Massachusetts
United-states
Suzanne-messere
Toronto-stock-exchange
Promis-neurosciences-inc
Nasdaq

vimarsana © 2020. All Rights Reserved.